monoclonal antibody BEC2
Sponsors
European Organisation for Research and Treatment of Cancer - EORTC
Conditions
Lung Cancer
Phase 3
Monoclonal Antibody Therapy Plus BCG in Treating Patients With Limited-Stage Small Cell Lung Cancer
CompletedNCT00006352
Start: 1999-09-30Updated: 2012-07-18
Vaccination Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
CompletedNCT00003279
Start: 1998-03-31Target: 500Updated: 2012-03-06